Celldex Therapeutics, Inc. presented final results yesterday from a Phase 1 study of CDX-301 in healthy volunteers that strongly support the initiation of a pilot study in hematopoietic stem cell transplantation later this year.
http://www.drugs.com/clinical_trials/positive-data-celldex-s-phase-1-study-cdx-301-support-initiation-pilot-study-hematopoietic-stem-15146.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+Drugscom-ClinicalTrials+%28Drugs.com+-+Clinical+Trials%29
http://www.drugs.com/clinical_trials/positive-data-celldex-s-phase-1-study-cdx-301-support-initiation-pilot-study-hematopoietic-stem-15146.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+Drugscom-ClinicalTrials+%28Drugs.com+-+Clinical+Trials%29
No comments:
Post a Comment